Document is current
Any future updates will be listed below
-
Authors
Eteleeb, Abdallah M.
Thunuguntla, Prasanth K.
Gelev, Kyla Z. https://orcid.org/0000-0003-3980-7189
Tang, Cynthia Y. https://orcid.org/0000-0001-5272-7170
Rozycki, Emily B.
Miller, Alexander
Lei, Jonathan T. https://orcid.org/0000-0002-0209-8051
Jayasinghe, Reyka G.
Dang, Ha X. https://orcid.org/0000-0002-9342-9249
White, Nicole M.
Reis-Filho, Jorge S. https://orcid.org/0000-0003-2969-3173
Mardis, Elaine R.
Ellis, Matthew J.
Ding, Li
Silva-Fisher, Jessica M. https://orcid.org/0000-0002-8146-9331
Maher, Christopher A. https://orcid.org/0000-0002-9035-603X
-
Funding
Funding for this research was provided by:
Susan G. Komen (Career Catalyst)
WUSTL | Washington University School of Medicine in St. Louis (T32CA113275)
Breast Cancer Research Foundation
Cancer Prevention and Research Institute of Texas
Avon Foundation for Women
Robert and Janice McNair Foundation
- License Information
-
More Information
Article History
Received: 16 July 2021
Accepted: 2 March 2022
First Online: 13 April 2022
Competing interests
: J.S.R-F. reports receiving personal/consultancy fees from Goldman Sachs, REPARE Therapeutics and Paige.AI, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics, Paige.AI and Personalis, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Genentech and InVicro, outside the scope of this study.
